Industry
Prescribing, Products and Patient Access: What to Expect from Medical Cannabis in 2026
The team at Prohibition Partners shares how they think things will shape up for medical cannabis in 2026.
Search
24 results for “cannabis-industry”
News
UK Medical Cannabis Awareness Month: Campaigners, Clinicians and Industry Leaders Join Forces to Drive Momentum
A quick rundown of the highlights so far, and what’s still left to look forward to.
News
What’s in Store for the European Cannabis Industry in 2025? (Part 2)
Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here. Growing demand for medical cannabis across Europe Medical cannabis demand across Europe has seen substantial growth, particularly […]
News
What’s in Store for the European Cannabis Industry in 2025? (Part 1)
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes […]
Industry
CanXChange introduces revolutionary CX financing service, redefining industry standards
CanXChange, the largest B2B cannabis platform in Europe and a leading financial technology company, is proud to announce the launch of its newest service, CX Financing. This innovative product is […]
FAQs
Do indica and sativa labels matter when it comes to cannabis?
The terms ‘indica’ and ‘sativa’ have been widely used to categorise cannabis products, but do these labels really matter?
News
What does Spain’s snap election mean for long-awaited medical cannabis legalisation?
The highly-anticipated roll out of legal access to medical cannabis in Spain is now under threat.
Industry
Swiss KannaVations: how we’re closing the gender health gap
How the female-led brand is tackling the huge unmet need in women’s healthcare through research and development.
Industry
MPs debate economic benefits of medical cannabis – key takeaways
The government’s ‘lack of understanding’ and ‘predictably poor’ response has been criticised.
Comment
Cannabis-drug interactions: addressing the gap in clinician education
An expert explores the need for more clinician education around cannabis.
Patients
Why are so many patients still accessing medical cannabis illegally in the UK?
Only a tiny fraction of UK medical cannabis patients are accessing the legal market. Why is that and what do we do about it?
News
Cannabis linked to positive public health outcomes – why the UK government should take note
Cannabis legalisation has been linked to a reduction in crime, traffic fatalities, suicides, and alcohol and tobacco consumption.
Industry
Women in cannabis: exploring gender, race and equity in the industry
Women, particularly women of colour, are woefully underrepresented in leadership positions across industries—cannabis can do better, and benefit.
Cannabis explained
Colonialism, class and crime: the racist roots of cannabis prohibition
Today Black people are still disproportionately targeted by cannabis laws, but how did these policies evolve?
News
NHS reimburses cost of unlicensed cannabis treatment in ‘rare’ adult case
Patients and advocates in the UK have welcomed the news but warned of a need to ‘manage expectations’.
Industry
Many Dispenseroo customers buying cannabis for medical reasons, says founder
What does the success of the illegal startup say about the current state of play?
Patients
Malta’s legal cannabis clubs could provide relief for struggling patients
Does Malta’s medical cannabis model favour industry profit over patient needs?
Industry
Deliveroo makes official complaint against cannabis seller Dispenseroo
Dispenseroo sells high-THC cannabis products online
Industry
“We know what patients want and can meet their expectations,” says AltoVerde founder
European cannabis producer AltoVerde aims to bring quality and transparency to the medical cannabis sector
Industry
Avida Global to manufacture medical cannabis products in the UK
The move is intended to improve patient access by supplying cannabis-based medicines produced in the UK.
Advocacy
Fresh moves to reform Ireland’s cannabis laws a welcome ‘first step’
A new bill will propose the decriminalisation of cannabis for personal use.
Advocacy
Campaigners back calls for government Office of Medicinal Cannabis
Industry leaders believe it would streamline the process of making cannabis medicines more widely available.
Advocacy
‘Tone deaf’ calls for cannabis to be Class A only fuel fear, stigma and misinformation
The Home Office has no current plans to upgrade cannabis to Class A, but even the suggestion is damaging.
News
President Biden’s move towards cannabis reform is step closer to justice for consumers
The announcement is a move towards normalising cannabis as both a medicine and a recreational drug, say experts.